cyclohexanol has been researched along with Disorders of Excessive Somnolence in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ii, Y; Tourian, K; Wang, Y | 1 |
| Hindmarch, I; Rigney, U; Stanley, N; Trick, L | 1 |
| Barbiroli, B; Bernardi, F; Cicognani, A; Lin, L; Lodi, R; Mignot, E; Montagna, P; Parmeggiani, A; Plazzi, G; Posar, A; Scano, MC; Tonon, C | 1 |
| Kasper, S; Montgomery, SA; Pande, AC; Tobias, K; Zornberg, GL | 1 |
| Han, C; Joe, SH; Jung, IK; Ko, YH; Lee, BH; Masand, PS; Pae, CU; Patkar, AA | 1 |
4 trial(s) available for cyclohexanol and Disorders of Excessive Somnolence
| Article | Year |
|---|---|
A 10-month, open-label evaluation of desvenlafaxine in Japanese outpatients with major depressive disorder.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Diagnostic and Statistical Manual of Mental Disorders; Disorders of Excessive Somnolence; Drug Monitoring; Female; Headache; Humans; Incidence; Intention to Treat Analysis; Japan; Male; Middle Aged; Nasopharyngitis; Nausea; Neurotransmitter Uptake Inhibitors; Psychiatric Status Rating Scales | 2013 |
A double-blind, randomized, 26-week study comparing the cognitive and psychomotor effects and efficacy of 75 mg (37.5 mg b.i.d.) venlafaxine and 75 mg (25 mg mane, 50 mg nocte) dothiepin in elderly patients with moderate major depression being treated in
Topics: Aged; Cognition; Cyclohexanols; Depressive Disorder; Disorders of Excessive Somnolence; Dizziness; Dothiepin; Double-Blind Method; Drug Administration Schedule; Female; Flicker Fusion; Humans; Male; Narcolepsy; Nausea; Psychometrics; Psychomotor Performance; Time Factors; Venlafaxine Hydrochloride | 2004 |
Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine.
Topics: Adult; Anticonvulsants; Anxiety Disorders; Cyclohexanols; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Placebos; Pregabalin; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder: a 12-week prospective, open-label, randomized, parallel-group trial.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Diagnostic and Statistical Manual of Mental Disorders; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nausea; Patient Dropouts; Prospective Studies; Somatoform Disorders; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia; Yawning | 2008 |
1 other study(ies) available for cyclohexanol and Disorders of Excessive Somnolence
| Article | Year |
|---|---|
Narcolepsy-cataplexy associated with precocious puberty.
Topics: Aspartic Acid; Benzhydryl Compounds; Cataplexy; Child; Creatine; Cyclohexanols; Disorders of Excessive Somnolence; Female; Hallucinations; Health Education; Humans; Hypothalamus; Intracellular Signaling Peptides and Proteins; Male; Modafinil; Narcolepsy; Neuropeptides; Night Terrors; Obesity; Orexins; Polysomnography; Puberty, Precocious; Television; Venlafaxine Hydrochloride | 2006 |